Abstract

Loss of the survival motor neuron gene (SMN1) is responsible for spinal muscular atrophy (SMA), the most common inherited cause of infant mortality. Even though the SMA phenotype is traditionally considered as related to spinal motor neuron loss, it remains debated whether the specific targeting of motor neurons could represent the best therapeutic option for the disease. We here investigated, using stereological quantification methods, the spinal cord and cerebral motor cortex of ∆7 SMA mice during development, to verify extent and selectivity of motor neuron loss. We found progressive post-natal loss of spinal motor neurons, already at pre-symptomatic stages, and a higher vulnerability of motor neurons innervating proximal and axial muscles. Larger motor neurons decreased in the course of disease, either for selective loss or specific developmental impairment. We also found a selective reduction of layer V pyramidal neurons associated with layer V gliosis in the cerebral motor cortex. Our data indicate that in the ∆7 SMA model SMN loss is critical for the spinal cord, particularly for specific motor neuron pools. Neuronal loss, however, is not selective for lower motor neurons. These data further suggest that SMA pathogenesis is likely more complex than previously anticipated. The better knowledge of SMA models might be instrumental in shaping better therapeutic options for affected patients.

Highlights

  • Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease

  • There are two SMN genes, the telomeric Survival Motor Neuron 1 (SMN1) coding for an ubiquitous protein, and its centromeric homolog SMN2 mostly generating a protein lacking exon 7 (Δ7-SMN), which is thought to be not functional or rapidly degraded [3,4,5]

  • Data were obtained from tissues harvested from Smn-/- (SMA) and Smn+/+ (WT) mice sacrificed at embryonic stage 19 (E19), checked by vaginal plug examination, postnatal day 4 (P4, presymptomatic stage), P9 and P13, considering P0 as the day of birth

Read more

Summary

Introduction

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease. It is the most common inherited cause of infant mortality with an incidence of around 1 in 10000 live births and a carrier frequency of 1:31 [1]. Based on the age of onset and disease severity, SMA has been classified into four main clinical types (I-IV) caused by homozygous loss or mutation of the Survival Motor Neuron 1 (SMN1) gene [2]. The molecular and cellular mechanisms by which SMN1 gene mutations eventually lead to a selective failure of the neuromuscular unit remain unclear

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call